Xeris Pharmaceuticals | XERS - EPS Earnings Per Share

Stock Price
6.05
Daily Change
0.10 1.68%
Monthly
14.15%
Yearly
40.37%
Q2 Forecast
5.92

Xeris Pharmaceuticals reported $0.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.01 -0.06 May/07




Eps Change Date
Celltrion KRW 1.55K 735.24 Mar/2026
Cspc Pharmaceutical CNY 0 0.08 Dec/2025
Deva Holding AS TRY 2.92 1.6 Sep/2023
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Divis Laboratories Ltd INR 21.98 3.99 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.09 0.12 Dec/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR -0.06 0.1 Dec/2023
Medical Developments International AUD 0 0 Dec/2025
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neuren Pharmaceuticals AUD 0.12 0.06 Dec/2025
Organigram Holdings CAD -0.16 0.02 Dec/2025
Ovoca Bio EUR -0.06 0.01 Jun/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pharma Mar EUR 3.34 3.57 Dec/2025
Qiagen NV USD 0.52 0.01 Dec/2025
Sartorius EUR 1.2 0.06 Mar/2026
Sino Biopharmaceutical CNY -0.06 0.22 Dec/2025
Supernus Pharmaceuticals USD -0.07 0.73 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Zealand Pharma A/S -8.34 2.6 Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025